Skip to main content

Research Oversight Committees

The Leukemia & Lymphoma Society's (LLS's) Research Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.


Medical & Scientific Affairs Committee

Advises the Board of Directors on a range of issues, including recommending funding for research grant awards and periodically reviewing LLS’s medical affairs

Jonathan D. Licht, MD (Chair) 
UF Gainesville

Omar Abdel-Wahab, MD
Memorial Sloan Kettering Cancer Center

Stephen Ansell, MD, PhD
Mayo Clinic, Rochester

Leif Bergsagel, MD
Mayo Clinic, Arizona

Ravi Bhatia, MD
The University of Alabama at Birmingham

Catherine Bollard, MD
Georgetown University

Lori Brown, PhD, MPH
FDA, Investigations Branch (formerly)

Renzo Canetta, MD +
Bristol-Myers Squibb (formerly)

Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center

Christopher Flowers, MD
The University of Texas MD Anderson Cancer Center

Janice Gabrilove, MD +
Mount Sinai

Irene Ghobrial, MD
Dana-Farber Cancer Institute

Larry Kwak, MD, PhD
City of Hope

Ruben Mesa, MD +
UT Health San Antonio


TAP Committee & Advisory Council

Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic initiative through which LLS partners directly with biotechnology companies to help accelerate the development of promising therapies

Committee

Casey Cunningham, MD (Chair) +
Santé Ventures

Ari Melnick, MD +
Weill Cornell Medicine

Jim Reddoch, PhD +
Royalty Pharma

Robert Rosen, JD +
Grewhawke Capital Advisors

Lilian Stern, JD +
Precision AQ

Advisory Council

Stephen Ansell, MD, PhD
Mayo Clinic Rochester

Philippe Armand, MD, PhD
Dana-Farber Cancer Institute

Asher Chanan-Khan, MD
Mayo Clinic, Jacksonville

Madhav Dhodapkar, MBBS
Emory University

Courtney DiNardo, MD
MD Anderson Cancer Center

Giulio Draetta, MD, PhD 
MD Anderson Cancer Center

Ian Flinn, MD, PhD
Sarah Cannon Research Institute

Christopher Flowers, MD
MD Anderson Cancer Center

Patrick Fortune, PhD, MBA
Partners Heathcare Systems

Mitul Gandhi, MD
Virginia Cancer Specialists

Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center

Tapan Kadia, MD
MD Anderson Cancer Center

Ross Levine, MD
Memorial Sloan Kettering Cancer Cente
r

Ronald Levy, MD
Stanford University School of Medicine

Frederick Locke, MD
Moffitt Cancer Center

Tak Mak, PhD
Princess Margaret Cancer Center

Ruben Mesa, MD +
UT Health San Antonio

Vern Norviel, JD
Wilson Sonsini Goodrich & Rosati

Susan O’Brien, MD
University of California, Irvine

Daniel Pollyea, MD
University of Colorado

Steven Rosen, MD
City of Hope

Michael Savona, MD
Vanderbilt University

Aaron Schimmer, MD, PhD
Princess Margaret Cancer Center

Jeff Sharman, MD
US Oncology

Robert Spiegel, MD
Spiegel Consulting LLC

Daniel Starcyznowski, PhD
Cincinnati Children’s Hospital

Keith Stewart, MD
Princess Margaret Cancer Center

Sarah Tasian, MD
Children’s Hospital of Philadelphia

Amit Verma, MD
Albert Einstein College of Medicine


+ National Board Member